These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3030773)

  • 1. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
    Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
    Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M; Högestätt ED; Uski TK
    Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive effects of eicosapentaenoic acid on isolated vascular smooth muscle.
    Yanagisawa A; Lefer AM
    Basic Res Cardiol; 1987; 82(2):186-96. PubMed ID: 3038070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of thromboxane actions in the isolated perfused rat heart.
    Stahl GL; Darius H; Lefer AM
    Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505.
    Sjöberg T; Steen S
    Acta Physiol Scand; 1989 Jun; 136(2):161-5. PubMed ID: 2528885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses.
    Cowan CL; Cohen RA
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H830-5. PubMed ID: 1653538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML; Allen GT
    J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A; Shirakura S; Higo K; Kubo K
    Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
    Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different potency of endothelium-derived relaxing factors against thromboxane, endothelin, and potassium chloride in intramyocardial porcine coronary arteries.
    Noll G; Bühler FR; Yang Z; Lüscher TF
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):120-6. PubMed ID: 1719280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of the thromboxane receptor antagonists BM 13.177 and BM 13.505 against U 46619-induced sudden death in rats.
    Smith EF; McDonald J
    Pharmacology; 1988; 36(5):340-7. PubMed ID: 3406046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
    Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
    Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of a novel thromboxane A2-receptor antagonist, S-145, on isolated monkey and cat arteries.
    Nakajima M; Ueda M
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):502-9. PubMed ID: 2476633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
    Stork AP; Cocks TM
    Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro.
    McKenniff MG; Norman P; Cuthbert NJ; Gardiner PJ
    Br J Pharmacol; 1991 Nov; 104(3):585-90. PubMed ID: 1839139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.